The PD-1 end of the ARC binds immobilized PD-L1 and PD-L2 at 2.08 and 1.76 nM affinity, respectively, and binds PD-L1 on human tumor cells in vitro and in vivo. The gene discussed is CD274; the disease is neoplasm.